Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
H Tsukaguchi, … , T Seido, M Inada
H Tsukaguchi, … , T Seido, M Inada
Published October 1, 1995
Citation Information: J Clin Invest. 1995;96(4):2043-2050. https://doi.org/10.1172/JCI118252.
View: Text | PDF
Research Article Article has an altmetric score of 6

Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

  • Text
  • PDF
Abstract

Nephrogenic diabetes insipidus (NDI) is most often an X-linked disorder in which urine is not concentrated due to renal resistance to arginine vasopressin. We recently identified four vasopressin type 2 receptor gene mutations in unrelated X-linked NDI families, including R143P, delta V278, R202C, and 804insG. All these mutations reduced ligand binding activity to < 10% of the normal without affecting mRNA accumulation. To elucidate whether the receptors are expressed on the cell surface, we analyzed biosynthesis and localization of tagged or untagged receptors stably expressed in Chinese hamster ovary (CHO) cells, using two antibodies directed against distinct termini. Whole-cell and surface labeling studies revealed that the R202C clone had both surface-localized (50-55 kD) and intracellular proteins (40 and 75 kD), similar to the wild-type AVPR2 clone, whereas the R143P and delta V278 clones lacked the surface receptors, despite relatively increased intracellular components. The 804insG mutant cell produced no proteins despite an adequate mRNA level. Immunofluorescence staining confirmed that the R202C mutant reaches the cell surface, whereas the R143P and delta V278 mutants are retained within the cytoplasmic compartment. Thus, R202C, R143P/delta V278, and 804insG result in three distinct phenotypes, that is, a simple binding impairment at the cell surface, blocked intracellular transport, and ineffective biosynthesis or/and accelerated degradation of the receptor, respectively, and therefore are responsible for NDI. This phenotypic classification will help understanding of molecular pathophysiology of this disorder.

Authors

H Tsukaguchi, H Matsubara, S Taketani, Y Mori, T Seido, M Inada

×

Total citations by year

Year: 2023 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2001 2000 1999 1998 1997 1996 1992 Total
Citations: 1 5 1 1 5 3 7 5 7 4 3 5 6 6 3 4 2 1 2 6 8 10 3 4 2 1 105
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (105)

Title and authors Publication Year
Exploring the diversity of AVPR2 in Primates and its evolutionary implications.
Fam BSO, Vargas-Pinilla P, Paré P, Landau L, Viscardi LH, Pissinatti A, Falótico T, Maestri R, Bortolini MC
Genetics and molecular biology 2023
Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases
LK Yang, ZS Hou, YX Tao
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021
Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus
Q Li, D Tian, J Cen, L Duan, W Xia
Journal of Endocrinological Investigation 2021
Cryo–electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex
J Bous, H Orcel, N Floquet, C Leyrat, J Lai-Kee-Him, G Gaibelet, A Ancelin, J Saint-Paul, S Trapani, M Louet, R Sounier, H Déméné, S Granier, P Bron, B Mouillac
Science Advances 2021
Integrating Population Variants and Protein Structural Analysis to Improve Clinical Genetic Diagnosis and Treatment in Nephrogenic Diabetes Insipidus
P Liao, T Xiang, H Li, Y Fang, X Fang, Z Zhang, Q Cao, Y Zhai, J Chen, L Xu, J Liu, X Tang, X Liu, X Wang, J Luan, Q Shen, L Chen, X Jiang, D Ma, H Xu, J Rao
Frontiers in Pediatrics 2021
Refractory Massive Ascites: An Unusual Presentation of Nephrogenic Diabetes Insipidus.
Pezantes MI, Krall P, Manríquez F, Arce I, Ardiles L
Kidney International Reports 2021
Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study
C D'Alessandri-Silva, M Carpenter, R Ayoob, J Barcia, A Chishti, A Constantinescu, KM Dell, J Goodwin, S Hashmat, S Iragorri, C Kaspar, S Mason, JM Misurac, M Muff-Luett, C Sethna, S Shah, P Weng, LA Greenbaum, JD Mahan
Frontiers in Pediatrics 2020
Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus
S Joshi, H Kvistgaard, K Kamperis, M Færch, S Hagstrøm, N Gregersen, S Rittig, JH Christensen
European Journal of Pediatrics 2018
Voltage-gated Sodium Channels: Structure, Function and Channelopathies
M Chahine
2017
Voltage-gated Sodium Channels: Structure, Function and Channelopathies
M Chahine
2017
Voltage-gated Sodium Channels: Structure, Function and Channelopathies
M Chahine
2017
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
S Milano, M Carmosino, A Gerbino, M Svelto, G Procino
International journal of molecular sciences 2017
Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus
S Joshi, P Brandstrom, N Gregersen, S Rittig, JH Christensen
Case Reports in Nephrology and Dialysis 2017
Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus
HK Ng, KG Harikumar, LJ Miller, BK Chow, G Valenti
PloS one 2016
Pediatric Kidney Disease
DF Geary, F Schaefer
Pediatric Kidney Disease 2016
A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree
WH Guo, Q Li, HY Wei, HY Lu, HQ Qu, M Zhu
J INT MED RES 2016
How genetic errors in GPCRs affect their function: Possible therapeutic strategies
H Stoy, VV Gurevich
Genes & Diseases 2015
Protein Traffic Disorders: an Effective High-Throughput Fluorescence Microscopy Pipeline for Drug Discovery
HM Botelho, I Uliyakina, NT Awatade, MC Proença, C Tischer, L Sirianant, K Kunzelmann, R Pepperkok, MD Amaral
Scientific Reports 2015
Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus
D Bockenhauer, DG Bichet
Nature Reviews Nephrology 2015
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study
AG Castaño, GP de Nanclares, L Madariaga, M Aguirre, S Chocron, A Madrid, FJ Tejedor, MG Campos, JS Pozo, RR Cano, M Espino, JM Vida, F Santos, VM Nieto, R Loza, LM Rodríguez, EH Barquero, N Printza, JA Camacho, L Castaño, G Ariceta
European Journal of Pediatrics 2015
A Rare Case of Congenital Diabetes Insipidus
T Rege, S Polsani, B Jim
Frontiers in Medicine 2015
Study of V2 vasopressin receptor hormone binding site using in silico methods
Yeganeh Sebti, Soroush Sardari, Hamid Mir Mohammad Sadeghi, Mohammad Hossein Ghahremani, Giulio Innamorati
Research in Pharmaceutical Sciences 2015
Effect of mutations in putative hormone binding sites on V2 vasopressin receptor function
Y Sebti, M Rabbani, H Mir Mohammad Sadeghi, S Sardari, M H Ghahremani, G Innamorati
Research in Pharmaceutical Sciences 2015
A novel therapeutic effect of statins on nephrogenic diabetes insipidus
L Bonfrate, G Procino, DQ Wang, M Svelto, P Portincasa
Journal of Cellular and Molecular Medicine 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
X-Linked Recessive Form of Nephrogenic Diabetes Insipidus in A 7-Year-Old Boy
A Janchevska, V Tasic, Z Gucev, M Krstevska-Konstantinova, HI Cheong
Balkan Journal of Medical Genetics 2014
Altered Agonist Sensitivity of a Mutant V2 Receptor Suggests a Novel Therapeutic Strategy for Nephrogenic Diabetes Insipidus
LS Erdélyi, A Balla, A Patócs, M Tóth, P Várnai, L Hunyady
Molecular Endocrinology 2014
Endogenous ADP-Ribosylation
F Koch-Nolte
2014
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment
HB Moeller, S Rittig, RA Fenton
Endocrine reviews 2013
Inside job: ligand-receptor pharmacology beneath the plasma membrane
JJ Babcock, M Li
Acta Pharmacologica Sinica 2013
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors: G protein-coupled receptors
SP Alexander, HE Benson, E Faccenda, AJ Pawson, JL Sharman, M Spedding, JA Peters, AJ Harmar
British Journal of Pharmacology 2013
Urinary concentration: different ways to open and close the tap
D Bockenhauer, DG Bichet
Pediatric Nephrology 2013
Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies
B Mouillac, C Mendre
Pharmacological Research 2013
Glycine receptor mouse mutants: model systems for human hyperekplexia: Hyperekplexia: a neurological disorder
N Schaefer, G Langlhofer, CJ Kluck, C Villmann
British Journal of Pharmacology 2013
Culturing Primary Rat Inner Medullary Collecting Duct Cells
D Faust, A Geelhaar, B Eisermann, J Eichhorst, B Wiesner, W Rosenthal, E Klussman
Journal of visualized experiments : JoVE 2013
Congenital nephrogenic diabetes insipidus: the current state of affairs
D Wesche, PM Deen, NV Knoers
Pediatric Nephrology 2012
Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin
R Bouley, P Nunes, B Andriopoulos, M McLaughlin, MJ Webber, HY Lin, JL Babitt, TJ Gardella, DA Ausiello, D Brown
American journal of physiology. Renal physiology 2012
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
RK Somvanshi, U Kumar
Pharmaceuticals (Basel, Switzerland) 2012
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: A case report and review of the literature
V Neocleous, N Skordis, C Shammas, E Efstathiou, NP Mastroyiannopoulos, LA Phylactou
Metabolism 2012
Familial forms of diabetes insipidus: clinical and molecular characteristics
M Babey, P Kopp, GL Robertson
Nature Reviews Endocrinology 2011
Pediatric Disorders of Water Balance
SA Ranadive, SM Rosenthal
Pediatric Clinics of North America 2011
Regulation of M3 Muscarinic Receptor Expression and Function by Transmembrane Protein 147S⃞
E Rosemond, M Rossi, SM McMillin, M Scarselli, JG Donaldson, J Wess
Molecular pharmacology 2011
Band 3 Edmonton I, a novel mutant of the anion exchanger 1 causing spherocytosis and distal renal tubular acidosis
C Chu, N Woods, N Sawasdee, H Guizouarn, B Pellissier, F Borgese, P Yenchitsomanus, M Gowrishankar, E Cordat
Biochemical Journal 2010
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain
AS Dixon, CS Lim
BioTechniques 2010
Analysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus
SD Moon, JH Kim, JY Shim, DJ Lim, BY Cha, JH Han
International journal of clinical and experimental medicine 2010
Current Topics in Membranes
TC Wagenknecht, Z Liu
Structure and Function of Calcium Release Channels 2010
Evidence that prokineticin receptor 2 exists as a dimer in vivo
S Marsango, MC di Patti, D Barra, R Miele
Cellular and Molecular Life Sciences 2010
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus
F Jean-Alphonse, S Perkovska, MC Frantz, T Durroux, C Méjean, D Morin, S Loison, D Bonnet, M Hibert, B Mouillac, C Mendre
Journal of the American Society of Nephrology : JASN 2009
A chemical-genetic approach to study G protein regulation of   cell function in vivo
JM Guettier, D Gautam, M Scarselli, IR de Azua, JH Li, E Rosemond, X Ma, FJ Gonzalez, BN Armbruster, H Lu, BL Roth, J Wess
Proceedings of the National Academy of Sciences 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Involvement of the V2 vasopressin receptor in adaptation to limited water supply
I Böselt, H Römpler, T Hermsdorf, D Thor, W Busch, A Schulz, T Schöneberg
PloS one 2009
Pediatric Disorders of Water Balance
SA Ranadive, SM Rosenthal
Endocrinology and metabolism clinics of North America 2009
Nephrogenic diabetes insipidus: treat with caution
T Boussemart, J Nsota, D MartinCoignard, G Champion
Pediatric Nephrology 2009
Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes
M Fujimoto, K Imai, K Hirata, R Kashiwagi, Y Morinishi, K Kitazawa, S Sasaki, T Arinami, S Nonoyama, E Noguchi
BMC Medical Genetics 2008
Comprehensive Pediatric Nephrology
R Gbadegesin, WE Smoyer
Comprehensive Pediatric Nephrology 2008
A novel disease-causing mutation in AVPR2: Q96H
M Lemaire, D Chitayat, DF Geary, DG Bichet, C Licht
Clinical Kidney Journal 2008
Regulation of CB 1 cannabinoid receptor trafficking by the adaptor protein AP-3
R Rozenfeld, LA Devi
The FASEB Journal 2008
Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers
M Canals, JF Lopez-Gimenez, G Milligan
Biochemical Journal 2008
Long-term growth of children with nephrogenic diabetes insipidus
H Lejarraga, MG Caletti, S Caino, A Jiménez
Pediatric Nephrology 2008
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
PM Conn, A Ulloa-Aguirre, J Ito, JA Janovick
Pharmacological reviews 2007
Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones
HI Cheong, HY Cho, HW Park, IS Ha, Y Choi
Nephrology 2007
A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene
A Ashida, D Yamamoto, H Nakakura, H Matsumura, S Uchida, S Sasaki, H Tamai
Pediatric Nephrology 2007
Diuretics in Pediatrics: Current Knowledge and Future Prospects
MM van der Vorst, JE Kist, AJ van der Heijden, J Burggraaf
Pediatric Drugs 2006
Controlling Protein Compartmentalization to Overcome Disease
JR Davis, M Kakar, CS Lim
Pharmaceutical Research 2006
Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications
YX Tao
Pharmacology & Therapeutics 2006
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus
JH Robben, NV Knoers, PM Deen
American journal of physiology. Renal physiology 2006
Genetic variation in G-protein-coupled receptors – consequences for G-protein-coupled receptors as drug targets
CM Tang, PA Insel
Expert Opinion on Therapeutic Targets 2005
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk
KA Beaumont, RA Newton, DJ Smit, JH Leonard, JL Stow, RA Sturm
Human Molecular Genetics 2005
Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway
R Hermosilla, M Oueslati, U Donalies, E Schönenberger, E Krause, A Oksche, W Rosenthal, R Schülein
Traffic (Copenhagen, Denmark) 2004
Functional Characterization of Melanocortin-4 Receptor Mutations Associated with Childhood Obesity
YX Tao, DL Segaloff
Endocrinology 2003
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor
A Pattaragarn, US Alon
Pediatric Nephrology 2003
NEPHROGENICDIABETESINSIPIDUS
JP Morello, DG Bichet
Annual Review of Physiology 2001
GENETICVARIATIONS ANDPOLYMORPHISMS OFG PROTEIN-COUPLEDRECEPTORS: Functional and Therapeutic Implications
BK Rana, T Shiina, PA Insel
Annual Review of Pharmacology and Toxicology 2001
Genetic variations in human G protein-coupled receptors: implications for drug therapy
W Sadee, E Hoeg, J Lucas, D Wang
AAPS PharmSci 2001
Molekularmedizinische Grundlagen von Endokrinopathien
D Ganten, K Ruckpaul, OE Janssen, AE Heufelder
2001
Risks and Benefits of Nonsteroidal Anti-Inflammatory Drugs in Children: A Comparison with Paracetamol
C Litalien, E Jacqz-Aigrain
Pediatric Drugs 2001
Association of Calnexin with Wild Type and Mutant AVPR2 that Cause Nephrogenic Diabetes Insipidus
JP Morello, A Salahpour, UE Petäjä-Repo, A Laperrière, M Lonergan, MF Arthus, IR Nabi, DG Bichet, M Bouvier
Biochemistry 2001
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
JP Morello, A Salahpour, A Laperrière, V Bernier, MF Arthus, M Lonergan, U Petäjä-Repo, S Angers, D Morin, DG Bichet, M Bouvier
Journal of Clinical Investigation 2000
Nephrogenic diabetes insipidus
PM Deen, N Marr, EJ Kamsteeg, BW van Balkom
Current Opinion in Nephrology and Hypertension 2000
Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus
R Postina, E Ufer, R Pfeiffer, NV Knoers, F Fahrenholz
Molecular and Cellular Endocrinology 2000
Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus
LS Barak, RH Oakley, SA Laporte, MG Caron
Proceedings of the National Academy of Sciences 2000
Nephrogenic diabetes insipidus:
PM Deen, N Marr, EJ Kamsteeg, BW van Balkom
Current Opinion in Nephrology and Hypertension 2000
The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues
R Schülein, K Zühlke, A Oksche, R Hermosilla, J Furkert, W Rosenthal
FEBS Letters 2000
Functional Rescue of the Nephrogenic Diabetes Insipidus-causing Vasopressin V 2 Receptor Mutants G185C and R202C by a Second Site Suppressor Mutation
R Schülein, K Zühlke, G Krause, W Rosenthal
The Journal of biological chemistry 2000
Nephrogenic Diabetes Insipidus: Functional Analysis of New AVPR2 Mutations Identified in Italian Families
E Albertazzi, D Zanchetta, P Barbier, S Faranda, A Frattini, P Vezzoni, M Procaccio, A Bettinelli, F Guzzi, M Parenti, B Chini
Journal of the American Society of Nephrology : JASN 2000
Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells
B Andersen-Beckh, M Dehe, R Schulein, B Wiesner, C Rutz, U Liebenhoff, W Rosenthal, A Oksche
Kidney International 1999
Conserved Extracellular Cysteine Pair in the M3 Muscarinic Acetylcholine Receptor Is Essential for Proper Receptor Cell Surface Localization but Not for G Protein Coupling
FY Zeng, A Soldner, T Schöneberg, J Wess
Journal of Neurochemistry 1999
Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride
V Kirchlechner, DY Koller, R Seidl, F Waldhauser
Archives of disease in childhood 1999
Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function
M Bai, S Trivedi, O Kifor, SJ Quinn, EM Brown
Proceedings of the National Academy of Sciences 1999
Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors
F Cogé, SP Guenin, A Renouard-Try, H Rique, C Ouvry, N Fabry, P Beauverger, JP Nicolas, JP Galizzi, JA Boutin, E Canet
Biochemical Journal 1999
Regulatory Peptides and Cognate Receptors
D Richter
1999
The Mutant Growth Hormone-Releasing Hormone (GHRH) Receptor of the Little Mouse Does Not Bind GHRH1
BD Gaylinn, VI DeAlmeida, CE Lyons, KC Wu, KE Mayo, MO Thorner
Endocrinology 1999
Molecular and Cellular Pediatric Endocrinology
S Handwerger
1999
Hormone Replacement Therapy
AW Meikle
1999
Nephrogenic Diabetes Insipidus Due to a New Mutation of the Arginine Vasopressin V2 Receptor Gene in a Girl Presenting with Non-Accidental Injury
CP Seem, JF Dossetor, MD Penney
Annals of Clinical Biochemistry 1999
Mutational analyses of AVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus: Two recurrent mutations, R137H and ΔV278, caused by the hypermutability at CpG dinucleotides
Y Shoji, T Takahashi, Y Suzuki, T Suzuki, K Komatsu, H Hirono, Y Shoji, T Yokoyama, H Kito, G Takada
Human Mutation 1998
Vasopressin Type-2 Receptor and Aquaporin-2 Water Channel Mutants in Nephrogenic Diabetes Insipidus
PM Deen, NV Knoers
The American Journal of the Medical Sciences 1998
Truncated V2 Vasopressin Receptors as Negative Regulators of Wild-Type V2 Receptor Function
X Zhu, J Wess
Biochemistry 1998
Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication
T Schöneberg, V Sandig, J Wess, T Gudermann, G Schultz
Journal of Clinical Investigation 1997
Advances in Molecular and Cellular Endocrinology
MR Pollak, EM Brown
Advances in Molecular and Cellular Endocrinology 1997
Biochemical Basis of Partial Nephrogenic Diabetes Insipidus Phenotypes
H Sadeghi, GL Robertson, DG Bichet, G Innamorati, M Birnbaumer
Molecular Endocrinology 1997
A newly identified membrane protein localized exclusively in intracellular organelles of neurons
Y Kadota, A Niiya, R Masaki, A Yamamoto, M Araki, S Taketani
Brain research. Molecular brain research 1997
Vasopressin receptors in health and disease
DG Bichet
Kidney International 1996
Functional characterization of five V2 vasopressin receptor gene mutations
D Wenkert, T Schoneberg, JJ Merendino, MS Pena, R Vinitsky, PK Goldsmith, J Wess, AM Spiegel
Molecular and Cellular Endocrinology 1996
Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment
N Knoers, LA Monnens
Pediatric Nephrology 1992

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 1 Wikipedia pages
9 readers on Mendeley
See more details